BFBerta Isabel Fidalgo

Berta Isabel Fidalgo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Berta Isabel Fidalgo has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Adán Fernández

    Department of Microbiology, Hospital Clinic, Barcelona, Spain

    1 shared publication
  • Ana González

    Department of Infectious Diseases, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain

    1 shared publication
  • Andrea Vergara

    Molecular Biology Core, Hospital Clinic of Barcelona, Barcelona, Spain

    1 shared publication
  • Andrea Vergara

    Microbiology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain; Institute of Global Health (ISGlobal), Barcelona, Spain; CIBERINFEC, CIBER in Infectious Diseases, ISCIII, Madrid, Spain; University of Barcelona, Faculty of Medicine, Barcelona, Spain

    1 shared publication
  • Aurea Mira

    Biomedical Diagnostic Centre (CDB), Hospital Clínic, University of Barcelona, Barcelona, Spain

    1 shared publication
  • Clara Ballesté-Delpierre

    CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto Salud Carlos III, 28029 Madrid, Spain

    1 shared publication

Latest Publications

  • Open Access

    Multidrug-resistant urethritis caused byHaemophilus parainfluenzae: susceptibility pattern and fosfomycin as an alternative treatment

    by Berta Isabel Fidalgo, Jordi Iglesies, David García, Andrea Vergara, Irene Fuertes de Vega, Laura Horvath, Yuliya Zboromyrska, Jordi Bosch, Ana González, José Riera-Monroig, et al.


  • Open Access

    Improved diagnosis of gastrointestinal infections using a semi-automated multiplex real-time PCR for detection of enteropathogens

    by Berta Fidalgo, Elisa Rubio, Victor Pastor, Marta Parera, Clara Ballesté-Delpierre, Mariana José Fernández, Genoveva Cuesta Chasco, Andrea Vergara, Yuliya Zboromyrska, Cristian Aylagas, et al.

    Introduction. The identification of enteropathogens is critical for the clinical management of patients with suspected gastrointestinal infection. The FLOW multiplex PCR system (FMPS) is a semi-automated platform (FLOW System, Roche) for multiplex real-time PCR analysis. Hypothesis/Gap Statement. FMPS has greater sensitivity for the detection of enteric pathogens than standard methods such as culture, biochemical identification, immunochromatography or microscopic examination. Aim.The diagnostic performance of the FMPS was evaluated and compared to that of traditional microbiological procedures. Methodology. A total of 10 659 samples were collected and analysed over a period of 7 years. From 2013 to 2018 (every July to September), samples were processed using standard microbiological culture methods. In 2019, the FMPS was implemented using real-time PCR to detect the following enteropathogens: Shigella spp., Salmonella spp., Campylobacter spp., Giardia intestinalis, Entamoeba histolytica, Blastocystis hominis, Cryptosporidum spp., Dientamoeba fragilis, adenovirus, norovirus and rotavirus. Standard microbiological culture methods (2013–2018) included stool culture, microscopy and immunochromatography. Results. A total of 1078 stool samples were analysed prospectively using the FMPS from July to September (2019): bacterial, parasitic and viral pathogens were identified in 15.3, 9.71 and 5.29 % of cases, respectively. During the same period of 6 years (2013–2018), the proportion of positive identifications using standard microbiological methods from 2013 to 2018 was significantly lower. A major significant recovery improvement was observed for all bacteria species tested: Shigella spp./enteroinvasive Escherichia coli (EIEC) (P Salmonella spp. (P Campylobacter spp. (P G. intestinalis, Cryptosporidium spp. and D. fragilis. Conclusion. These results support the value of multiplex real-time PCR analysis for the detection of enteric pathogens in laboratory diagnosis with outstanding performance in identifying labile micro-organisms. The identification of unsuspected micro-organisms for less specific clinical presentations may also impact on clinical practice and help optimize patient management.